search
Back to results

Prospective Evaluation of Osseous Integration in ACL Reconstruction Comparing Tightrope vs Interference Screw Fixation

Primary Purpose

ACL - Anterior Cruciate Ligament Rupture

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Biocomposite intereference screw femoral tunnel fixation
Endobutton (Tightrope) femoral tunnel fixation
Sponsored by
Kelsey-Seybold Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for ACL - Anterior Cruciate Ligament Rupture

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • patients between the ages of 18 and 50 able to provide informed consent with ACL tears meeting the indications for reconstruction and electing to undergo reconstruction with an Achilles tendon allograft.

Exclusion Criteria:

  • History of prior ACL reconstruction
  • pregnancy
  • inflammatory disease
  • a primary bone disorder
  • those taking bone resorption inhibitor medications
  • those with injuries to the collateral ligaments or posterior cruciate ligament

Sites / Locations

  • Kelsey-Seybold Clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Aperture (biocomposite screw) fixation

Suspensory (endobutton) fixation

Arm Description

16 patients in this arm underwent ACL reconstruction with the allograft fixed in the femoral tunnel with a biocomposite interference screw (BioComposite Screw, Arthrex, North Naples, FL; or MILAGRO screw, DePuy Mitek, Raynham, MA, USA). Intervention: ACL reconstruction with the allograft fixed in the femoral tunnel with a biocomposite interference screw.

17 patients in this arm underwent ACL reconstruction with the allograft secured in the femoral tunnel with a cortical button (TightRope, Arthrex, North Naples, FL, USA). Intervention: ACL reconstruction with the allograft secured in the femoral tunnel with a cortical button.

Outcomes

Primary Outcome Measures

Femoral Ossification Score
Amount of ossification (osseous integration) around the graft at 6 months post-operatively as seen on CT scan. Score range: 0 (minimum) - 5 (maximum). Score of 0 is the worst outcome and indicates no ossification in the femoral tunnel as seen on CT scan. Score of 5 indicates full ossification of the tunnel (best outcome) as seen on CT scan. Scores in between indicate partial ossification (each number 20% more ossification than the previous score).

Secondary Outcome Measures

Pain (VAS)
Pain as assessed by the visual analog scale. Scale of 0-10 (0 is the best [no pain], 10 is the worst [severe pain])
Knee range of motion
Knee range of motion (measured in degrees [angle] from full extension to full flexion). 0 degrees is considered full extension. 140 degrees is full flexion.
International Knee Documentation Committee (IKDC) subjective knee score
The IKDC is a patient-completed tool, which contains sections on knee symptoms (7 items), function (2 items), and sports activities (2 items). Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

Full Information

First Posted
February 7, 2019
Last Updated
February 14, 2019
Sponsor
Kelsey-Seybold Clinic
Collaborators
Baylor College of Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT03841500
Brief Title
Prospective Evaluation of Osseous Integration in ACL Reconstruction Comparing Tightrope vs Interference Screw Fixation
Official Title
Prospective Evaluation of Osseous Integration and Patient Outcomes In Allograft ACL Reconstruction Comparing Tightrope Versus Biocomposite Interference Screw Fixation
Study Type
Interventional

2. Study Status

Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
January 2016 (Actual)
Primary Completion Date
January 2017 (Actual)
Study Completion Date
January 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kelsey-Seybold Clinic
Collaborators
Baylor College of Medicine

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of our study was to compare osseous integration of the bone block in Achilles tendon allograft ACL reconstruction using a cortical button versus biocomposite interference screw fixation. The primary outcome was bone block incorporation within the femoral tunnel at six months. Our null hypothesis was that there is no difference in osseous incorporation or outcome with either type of femoral fixation in primary ACL reconstruction with Achilles tendon allograft. Our secondary outcomes were pain and clinical outcome scores between the two groups.
Detailed Description
After obtaining institutional review board approval the investigators conducted this prospective randomized controlled trial with goal of 1:1 allocation ratio between the two study groups. All subjects were recruited at the preoperative appointments. The senior investigator discussed ACL reconstruction with the patients. Appropriate preoperative counseling was performed regarding graft options. If inclusion criteria were met, patients received information about the study. Informed consent was obtained from those choosing to enroll in the study including consent for a CT scan at the six month postoperative time period. The patients were randomized for fixation technique on the day of surgery from a list using the medical record number. Patients underwent ACL reconstruction with Achilles tendon allograft with femoral-sided bone block fixation with either (1) a biocomposite interference screw (aperture fixation) or (2) cortical button (suspensory fixation). The inclusion criteria included patients between the ages of 18 and 50 able to provide informed consent with ACL tears meeting the indications for reconstruction and electing to undergo reconstruction with an Achilles tendon allograft. Excluded patients included those with a history of prior ACL reconstruction, pregnancy, inflammatory disease, a primary bone disorder, those taking bone resorption inhibitor medications, and those with injuries to the collateral ligaments or posterior cruciate ligament. All surgeries were performed by a single surgeon at a single institution using the same technique. Initial diagnosis of ACL deficiency was made on physical exam and magnetic resonance imaging. This was confirmed with arthroscopy at the beginning of the case. The Achilles-calcaneal bone allograft was thawed. The tendinous portion was tubularized and whip-stitched with a locking Fiberloop suture (Arthrex, North Naples, FL, USA). Sutures were passed through the bone block and the graft diameter was measured. The graft was then pre-tensioned. Femoral tunnels were made using the anteromedial portal at 120 degrees of knee flexion. The tibial tunnel was created using an outside-in technique over a pin centered at the ACL footprint. In the aperture fixation group, the bone graft end was pulled through into the femoral tunnel and secured with a biocomposite interference screw (BioComposite Screw, Arthrex, North Naples, FL; or MILAGRO screw, DePuy Mitek, Raynham, MA, USA). In the suspensory fixation group, a cortical button (TightRope, Arthrex, North Naples, FL, USA) was pulled through the femoral cortex and used to shuttle the Achilles bone plug into the femoral tunnel until it was just recessed within the medial intercondylar surface. In both groups, tibial fixation was identical with a bioabsorbable interference screw (BioComposite Screw, Arthrex, North Naples, FL, USA or Milagro screw) and a backup knotless anchor (4.5 mm Biomet Peek knotless anchor, Biomet, Warsaw, IN, USA). The graft was fixed at near full extension after having cycled the knee through range of motion with the graft tensioned. All patients underwent a specified ACL post-operative rehabilitation protocol depending on concomitant pathology. Cycling was permitted at the six-week mark. In-line jogging typically was allowed at four months with initiation of pivoting motions at seven to eight months. Full return to sports was allowed after nine months. Younger patients enrolled in a sports metrics program followed by a functional ACL exam prior to return to sports. A commuted tomography (CT) scan of the operative knee was obtained postoperatively at six months. Demographic data including age, gender, and body mass index were collected. The primary outcome measure was bony incorporation of the bone block within the femoral tunnel with CT scan. This was assessed with the femoral ossification score as determined by three board certified radiologists. The femoral ossification score was devised as a practical means of semi-quantitatively assessing the degree of bone incorporation around the femoral bone plug or screw fixation device present in each patient. Each CT scan score assessment was performed by one of three musculoskeletal fellowship-trained radiologists. Whenever an ossification score was deemed to be borderline between two categories, a consensus score was determined by two of the radiologists. The impression in the CT report included the femoral ossification score as well as a footnote with the entire scale to explain the score. Secondary outcome measures included pain score on a visual analogue scale (VAS) obtained preoperatively, at the first post-operative visit, and at return to sports. Physical examination findings included range of motion (ROM) and Lachman grading which were measured preoperatively and at return to sporting activities. Finally, the International Knee Documentation Committee (IKDC) subjective knee evaluation score, Tegner-Lysholm Knee score, and Cincinnati Knee Rating system scores were assessed both pre-operatively and post-operatively at return to sports.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
ACL - Anterior Cruciate Ligament Rupture

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
37 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Aperture (biocomposite screw) fixation
Arm Type
Active Comparator
Arm Description
16 patients in this arm underwent ACL reconstruction with the allograft fixed in the femoral tunnel with a biocomposite interference screw (BioComposite Screw, Arthrex, North Naples, FL; or MILAGRO screw, DePuy Mitek, Raynham, MA, USA). Intervention: ACL reconstruction with the allograft fixed in the femoral tunnel with a biocomposite interference screw.
Arm Title
Suspensory (endobutton) fixation
Arm Type
Active Comparator
Arm Description
17 patients in this arm underwent ACL reconstruction with the allograft secured in the femoral tunnel with a cortical button (TightRope, Arthrex, North Naples, FL, USA). Intervention: ACL reconstruction with the allograft secured in the femoral tunnel with a cortical button.
Intervention Type
Device
Intervention Name(s)
Biocomposite intereference screw femoral tunnel fixation
Intervention Description
ACL reconstruction using biocomposite intereference screw for femoral tunnel fixation
Intervention Type
Device
Intervention Name(s)
Endobutton (Tightrope) femoral tunnel fixation
Intervention Description
ACL reconstruction using endobutton (Tightrope) for femoral tunnel fixation
Primary Outcome Measure Information:
Title
Femoral Ossification Score
Description
Amount of ossification (osseous integration) around the graft at 6 months post-operatively as seen on CT scan. Score range: 0 (minimum) - 5 (maximum). Score of 0 is the worst outcome and indicates no ossification in the femoral tunnel as seen on CT scan. Score of 5 indicates full ossification of the tunnel (best outcome) as seen on CT scan. Scores in between indicate partial ossification (each number 20% more ossification than the previous score).
Time Frame
6 months post-op
Secondary Outcome Measure Information:
Title
Pain (VAS)
Description
Pain as assessed by the visual analog scale. Scale of 0-10 (0 is the best [no pain], 10 is the worst [severe pain])
Time Frame
Obtained preoperatively (right before surgery); 2 weeks after surgery; and 6 months after surgery
Title
Knee range of motion
Description
Knee range of motion (measured in degrees [angle] from full extension to full flexion). 0 degrees is considered full extension. 140 degrees is full flexion.
Time Frame
Obtained preoperatively (right before surgery) and at 6 months after surgery
Title
International Knee Documentation Committee (IKDC) subjective knee score
Description
The IKDC is a patient-completed tool, which contains sections on knee symptoms (7 items), function (2 items), and sports activities (2 items). Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).
Time Frame
Obtained preoperatively (right before surgery) and at 6 months after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: patients between the ages of 18 and 50 able to provide informed consent with ACL tears meeting the indications for reconstruction and electing to undergo reconstruction with an Achilles tendon allograft. Exclusion Criteria: History of prior ACL reconstruction pregnancy inflammatory disease a primary bone disorder those taking bone resorption inhibitor medications those with injuries to the collateral ligaments or posterior cruciate ligament
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anup Shah
Organizational Affiliation
Kelsey-Seybold Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kelsey-Seybold Clinic
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Primary and secondary outcome measures (de-identified)
IPD Sharing Time Frame
Data is already available (study has been completed)
IPD Sharing Access Criteria
Standard

Learn more about this trial

Prospective Evaluation of Osseous Integration in ACL Reconstruction Comparing Tightrope vs Interference Screw Fixation

We'll reach out to this number within 24 hrs